Jonathan Page, PhD
Jonathan has spent his career deciphering the genetic and biochemical secrets of medicinal plants, including the production of THC. He co-led the Canadian team that first sequenced the cannabis genome, and his work has helped discover the biochemical pathway of the major cannabinoids.Read full bio
John Coleman, PhD
Co-founder and President
John has a wide-ranging scientific and business background. His PhD research on anticancer compounds produced the drug candidate HTI-286 that was licensed to Wyeth, and it progressed to Phase II clinical trials. He’s also an inventor on four patents and the author of thirteen publications.Read full bio
Bill Adams, CPA, CA
Chief Corporate Officer
Bill has over 25 years of strategic financial management experience as the Chief Financial Officer of both public and private companies in high-growth, technology, and life sciences industries. He brings a wealth of knowledge in overseeing and driving change in complex commercial organizations, as well as managing the challenges of significant growth and raising financing in both the private and public markets.
Bill is a chartered professional accountant and holds a BComm from the University of British Columbia.
Lana Culley, BSc
Vice President, Business Development
Responsible for Anandia’s sales and marketing activities, research and business partnerships, and the strategic management of intellectual property, Lana has extensive experience in the commercialization of crop varieties and other technologies.
Lana has held positions in both the public and private sectors. Prior to joining Anandia, Lana was the Director of Business Development at Vineland Research and Innovation Centre, a private, not-for-profit research company focused on horticultural crops.